gptkbp:instanceOf
|
gptkb:disease
|
gptkbp:affects
|
humans
|
gptkbp:antiviralTreatment
|
gptkb:baloxavir_marboxil
gptkb:oseltamivir
gptkb:zanamivir
peramivir
|
gptkbp:associatedWith
|
gptkb:avian_influenza
swine influenza
|
gptkbp:causedBy
|
gptkb:influenza_virus
|
gptkbp:complication
|
gptkb:pneumonia
bronchitis
sinus infections
worsening of chronic medical conditions
|
gptkbp:contagiousPeriod
|
1 day before to 5-7 days after symptom onset
|
gptkbp:firstDescribed
|
1933
|
https://www.w3.org/2000/01/rdf-schema#label
|
human influenza
|
gptkbp:ICD-10_code
|
gptkb:J11
J10
|
gptkbp:incubationPeriod
|
1-4 days
|
gptkbp:mortalityRate
|
generally low
|
gptkbp:notableOutbreaks
|
gptkb:1918_flu_pandemic
gptkb:2009_H1N1_pandemic
gptkb:1957_Asian_flu
gptkb:1968_Hong_Kong_flu
|
gptkbp:prevention
|
influenza
|
gptkbp:riskFactor
|
pregnant women
elderly
young children
immunocompromised individuals
|
gptkbp:season
|
more common in winter
|
gptkbp:subspecies
|
gptkb:influenza_A
gptkb:influenza_B
gptkb:influenza_C
gptkb:influenza_D
|
gptkbp:symptom
|
fever
fatigue
cough
muscle aches
sore throat
|
gptkbp:transmission
|
direct contact
airborne droplets
|
gptkbp:treatment
|
antiviral drugs
|
gptkbp:vaccineType
|
gptkb:inactivated_influenza_vaccine
gptkb:live_attenuated_influenza_vaccine
recombinant influenza vaccine
|
gptkbp:WHOClassification
|
vaccine-preventable disease
|
gptkbp:bfsParent
|
gptkb:Swine_influenza
|
gptkbp:bfsLayer
|
5
|